Impression Cytology of the Conjunctival Epithelium after Antiglaucomatous Treatment with Latanoprost

Abstract

Purpose

To study nongoblet and goblet epithelial conjunctival cells after several treatment periods with latanoprost, a prostaglandin analogue.

Methods

Twelve patients (20 eyes) were studied before the onset of treatment and after 1, 3, and 6 months of latanoprost use. Impression cytology was carried out to analyze cellular density and morphologic parameters such as minimum and maximum diameter and area.

Results

Nongoblet epithelium cell density did not change over the treatment period. The density of goblet cells increased after 1 month of use, but returned to initial cell density after longer treatment periods. Nongoblet epithelial cells underwent a significant reduction in size after 1, 3, and 6 months of treatment. In addition, the minimum/maximum diameter ratio suggested that after 1 month there were some changes in shape (a slight elongation) when compared to cells of untreated patients. Nevertheless, after longer treatment periods, the cells regained their original shape. No changes in size were observed in goblet cells, except for a slight decrease in maximum diameter after 6 months of treatment, which suggests that the cells became more rounded.

Conclusions

The density of nongoblet epithelial cells does not change after different treatment periods with latanoprost. However, their size decreases and after short treatment periods their shape also undergoes changes. The density of goblet cells increases after 1 month of treatment, but decreases again after longer periods. Their size does not undergo any modification, although there is a variation in shape after 6 months of treatment.

Keywords

Conjunctive epithelium Nongoblet epithelial cell Goblet epithelial cell Impression cytology

Get full access to this article

View all access options for this article.

References

Le Jeume

Munera

Hughes

F.C.

. Systemic effects of three β₁-blocker eyedrops: comparison in healthy volunteers of β₁ and β₂-adrenoreceptor inhibition. Clin Pharmacol Ther 1990; 47: 578–83.

Brooks

A.M.V.

Gillies

W.E.

. Ocular β₁-blockers in glaucoma management. Clinical pharmacology aspects. Drugs Aging 1992; 2: 208–21.

Strahlman

E.R.

Vogel

Tipping

Clineschmidt

C.M.

. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Ophthalmology 1996; 103: 1283–92.

Stewart

W.C.

Holmes

K.T.

Mark

. Washout periods for brimonidine 0.2% and latanoprost 0.005%. Am J Ophthalmol 2001; 131: 798–9.

Toris

C.B.

Zhan

G.L.

Zhao

Camras

C.B.

Yablonski

M.E.

. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol 2001; 131: 722–8.

Garcia Sanchez

Garcia

Feijó J.

. Mantenimiento médico del glaucoma. Arch Soc Esp Oftalmol 2000; 75: 11–20.

Nuzzi

Emanuelli

Fiazzo

. Evaluation of conjunctival tearing functionality and impression cytology in glaucomatous patients using long-term-medication. New Trends Ophthalmol 1996; 11: 41–6.

Camras

C.B.

Alm

Watson

Stjernschantz

. Latanoprost. A prostaglandin analog for glaucoma therapy. Ophthalmology 1996; 103: 1916–24.

Stewart

W.C.

Sharpe

Stewart

J.A.

Holmes

K.T.

Latham

K.E.

. Additive efficacy of unoprostone isopropyl 0.12% to latanoprost 0.005%. Am J Ophthalmol 2001; 131: 339–44.

10.

Waevar

R.E.

Bullock

Ballal

. Cystoid macular edema and anterior uveitis associated with latanoprost used. Experience and incidence in a retrospective review of 84 patients. Ophthalmology 1998; 105: 263–8.

11.

Miyake

Ota

Meekbo

Ichihashi

Miyake

. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 1999; 117: 34–40.

12.

Egbert

P.R.

Lauber

Maurice

M.D.

. A simple conjunctival biopsy. Am J Ophthalmol 1977; 84: 798–801.

13.

Nelson

J.D.

. Impression cytology. Cornea 1988; 7: 71–81.

14.

Kinosita

Kiorpes

T.C.

Friend

Thoft

R.A.

. Goblet cell density in ocular surface diseases. Arch Ophthalmol 1983; 101: 1282–7.

15.

Tseng

S.H.

Chen

Y.T.

Cheng

H.C.

Huang

F.C.

Lee

S.C.

Chen

F.K.

. Impression cytology study of conjunctival epithelial phenotypes on the healing ocular surface after pterygium excision. Cornea 2001; 20: 244–50.

16.

Reddy

P.M.

Reddy

S.C.

. Conjunctival impression cytology in dry eye states. Ind J Ophthalmol 1991; 39: 22–4.

17.

Nelson

J.D.

Wright

J.C.

. Conjunctival goblet cell densities. Arch Ophthalmol 1983; 102: 1049–51.

18.

Tseng

S.C.G.

. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985; 92: 728–33.

19.

Tseng

S.C.

Hirst

L.W.

Maumenee

A.E.

Kenyon

K.R.

Sun

T.T.

Green

W.R.

. Possible mechanism for the loss of goblet cells in mucin-deficient disorders. Ophthalmology 1984; 91: 545–52.

20.

Widengard

Maepea

Alm

. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. Br J Ophthalmol 1998; 82: 404–6.

21.

Studer

M.E.

Martin

C.L.

Stiles

. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats. Am J Vet Res 2000; 61: 1220–4.

22.

DuBiner

Cooke

Dirks

Stewart

W.C.

VanDenburgh

A.M.

Felix

. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol 2001; 45: S353–60.

23.

Mietz

Schlötzer-Schrehardt

Strassfeld

Krieglstein

G.K.

. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 2001; 42: 679–87.